Molecular epidemiological designs for prognosis

Molecular Epidemiology: Applications in Cancer and Other Human Diseases

Volumn , Issue , 2016, Pages 41-52

  Ulrich, Cornelia M ^a   Ambrosone, Christine B ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953655882     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (40)

1. Institute of Medicine, National Research Council. From Cancer Patient to Cancer Survivor:Lost in Transition. Washington, DC: National Academies Press; 2006.
2. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88(10): 2398-2424.
3. Panel PsC. Living Beyond Cancer: Finding a New Balance. National Cancer Institute; 2003.
4. National Cancer Institute. Eliminating the Suffering and Death Due to Cancer. NCI Cancer Bulletin 2006; 3(40): 1-8.
5. American Institute for Cancer Research. Nutrition Guidelines for Cancer Survivors After Treatment. Available at: http://www.aicr.org/information/survivor/guidelines.lasso. Accessed January 20, 2006.
6. Satia JA, CampbellMK, Galanko JA, et al. Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev 2004; 13(6): 1022-1031.
7. Maunsell E, Drolet M, Brisson J, et al. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol 2002; 20(4): 1017-1025.
8. Patterson RE, Neuhouser ML, Hedderson MM, et al. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc 2003; 103(3): 323-328.
9. Maskarinec G, Murphy S, Shumay DM, et al. Dietary changes among cancer survivors. Eur J Cancer Care (Engl) 2001; 10(1): 12-20.
10. Thomson CA, Flatt SW, Rock CL, et al. Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J Am Diet Assoc 2002; 102(6): 801-808.
11. Salminen E, Bishop M, Poussa T, et al. Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer. 2004; 58(1): 137-144.
12. Wayne SJ, Lopez ST, Butler LM, et al. Changes in dietary intake after diagnosis of breast cancer. J Am Diet Assoc 2004; 104(10): 1561-1568.
13. Ambrosone CB, Jiyoung A, Schoenenberger V. Antioxidant supplements, genetics and chemotherapy outcomes. Current Cancer Therapy Reviews 2005; 1(3): 1-8.
14. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005; 97(7): 481-488.
15. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999; 13(7): 1003-1008. (discussion 1008, 1011-1002).
16. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297(21): 2351-2359.
17. Ulrich CM, Potter JD. Folate and cancer-timing is everything. JAMA 2007; 297(21): 2408-2409.
18. Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006; 11(7): 742-752.
19. Ambrosone CB, Rebbeck TR, Morgan GJ, et al. New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival. Cancer Epidemiol Biomarkers Prev 2006; 15(11): 2042-2046.
20. Ulrich CM, Robien K, McLeod HL. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer 2003; 3(12): 912-920.
21. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23(3): 609-618.
22. Amend K, Hicks D, Ambrosone CB. Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res 2006; 66(17): 8327-8330.
23. Popat S, Matakidou A, Houlston RS. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 1 2004; 22(3): 529-536.
24. Rebbeck TR, Ambrosone CB, Bell DA, et al. SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2004; 13(5): 681-687.
25. Ulrich CM. Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J Nutr 2005; 135(11): 2698-2702.
26. Moran AE, Hunt DH, Javid SH, et al. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/þ mice. J Biol Chem 2004; 279(41): 43261-43272.
27. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 2006; 55(10): 1387-1389.
28. Bueno R, Appasani K, Mercer H, et al. The alpha folate receptor is highly activated in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001; 121(2): 225-233.
29. Wu M, Gunning W, Ratnam M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiology, Biomarkers & Prevention 1999; 8(9): 775-782.
30. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994; 73(9): 2432-2443.
31. Popat S, Chen Z, Zhao D, et al. A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer. Ann Oncol 2006: 1810-1817.
32. Yasuno M, Mori T, Koike M, et al. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma. Oncol Rep 2005; 13(3): 405-412.
33. Odin E, Wettergren Y, Nilsson S, et al. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res 2003; 9(16 pt 1): 6012-6019.
34. Robien K, Boynton A, Ulrich CM. Pharmacogenetics of folate-related drug targets in cancer treatment. Pharmacogenomics 2005; 6(7): 673-689.
35. Lenz H-J. Pharmacogenomics and colorectal cancer. Adv Exp Med Biol 2006; 587: 211-231.
36. Kushi LH, Kwan ML, Lee MM, et al. Lifestyle factors and survival in women with breast cancer. 2007; 137(1 suppl): 236S-242S.
37. Meyerhardt JA, Niedzwiecki D, Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007; 298(7): 754-764.
38. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 18 2007; 298(3): 289-298.
39. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 1 2002; 20(3): 791-796.
40. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 2005; 103(2): 402-408.